Protective effects of prepubertal genistein exposure on mammary tumorigenesis are dependent on BRCA1 expression

Cancer Prevention Research

Volumn 4, Issue 9, 2011, Pages 1436-1448

  De Assis, Sonia ^a   Warri, Anni ^a   Benitez, Carlos ^a   Helferich, William ^b   Hilakivi Clarke, Leena ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHIREGULIN; BRCA1 PROTEIN; CYTOKERATIN 18; CYTOKERATIN 5; DIMETHYLBENZ[A]ANTHRACENE; ESTROGEN RECEPTOR ALPHA; GENISTEIN; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; PROGESTERONE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GROWTH; CANCER RISK; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; MOUSE; MOUSE STRAIN; NONHUMAN; PREPUBERTY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK REDUCTION; TISSUE LEVEL; TUMOR SUPPRESSOR GENE; UPREGULATION; WILD TYPE;

ANIMAL FEED; ANIMALS; BRCA1 PROTEIN; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BRCA1; GENISTEIN; GENOTYPE; HETEROZYGOTE; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECEPTOR, ERBB-2; RECEPTORS, PROGESTERONE;

EID: 80052605877     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-10-0346     Document Type: Article

References (57)

1. Korde L.A., Wu A.H., Fears T., Nomura A.M., West D.W., Kolonel L.N., et al. Childhood soy intake and breast cancer risk in Asian-American women. Cancer Epidemiol Biomarkers Prev 2009;18:1050-1059
2. Shu X.O., Jin F., Dai Q., Wen W., Potter J.D., Kushi L.H., et al. Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiol Biomarkers Prev 2001;10: 483-488 (Pubitemid 32701634)
3. Wu A.H., Wan P., Hankin J., Tseng C.C., Yu M.C., Pike M.C. Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis 2002;23:1491-1496 (Pubitemid 35012429)
4. Thanos J., Cotterchio M., Boucher B.A., Kreiger N., Thompson L.U. Adolescent dietary phytoestrogen intake and breast cancer risk (Canada). Cancer Causes Control 2006;17:1253-1261 (Pubitemid 44772825)
5. Lee S.A., Shu X.O., Li H., Yang G., Cai H., Wen W., et al. Adolescent and adult soy food intake and breast cancer risk: Results from the Shanghai Women's Health Study. Am J Clin Nutr 2009;89:1920-1926
6. Warri A., Saarinen N.M., Makela S.I., Hilakivi-Clarke L. The role of early life genistein exposures in modifying breast cancer risk. Br J Cancer 2008;98:1485-1493 (Pubitemid 351652325)
7. Newmark H.L., Yang K., Lipkin M., Kopelovich L., Liu Y., Fan K., Shinozaki H.A. Western-style diet induces benign and malignant neoplasms in the colon of normal C57Bl/6 mice. Carcinogenesis 2001;22:1871-1875 (Pubitemid 33064854)
8. Kuiper G.G., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., Van der Saag P.T. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998;139:4252-4263 (Pubitemid 28513713)
9. Chang E.C., Charn T.H., Park S.H., Helferich W.G., Komm B., Katzenellenbogen J.A., et al. Estrogen Receptors alpha and beta as determinants of gene expression: Influence of ligand, dose, and chromatin binding. Mol Endocrinol 2008;22:1032-1043 (Pubitemid 351629605)
10. Yang X., Yang S., McKimmey C., Liu B., Edgerton S.M., Bales W., et al. Genistein induces enhanced growth promotion in ER-positive/erbB- 2-overexpressing breast cancers by ER-erbB-2 cross talk and p27/ kip1 downregulation. Carcinogenesis 2010;31:695-702.
11. Di X., Yu L., Moore A.B., Castro L., Zheng X., Hermon T., Dixon D. A low concentration of genistein induces estrogen receptor-alpha and insulin- like growth factor-I receptor interactions and proliferation in uterine leiomyoma cells. Hum Reprod 2008;23:1873-1883 (Pubitemid 352019996)
12. Cabanes A., Wang M., Olivo S., De Assis S., Gustafsson J.A., Khan G., et al. Prepubertal estradiol and genistein exposures up-regulate BRCA1 mRNA and reduce mammary tumorigenesis. Carcinogenesis 2004;25:741-748 (Pubitemid 38618526)
13. Su Y., Eason R.R., Geng Y., Till S.R., Badger T.M., Simmen R.C. In utero exposure to maternal diets containing soy protein isolate, but not genistein alone, protects young adult rat offspring from NMU-induced mammary tumorigenesis. Carcinogenesis 2007;28:1046-1051 (Pubitemid 47072189)
14. Zhang M., Liu X., Holman C.D. Effect of dietary intake of isoflavones on the estrogen and progesterone receptor status of breast cancer. Nutr Cancer 2010;62:765-773
15. Helferich W.G., Andrade J.E., Hoagland M.S. Phytoestrogens and breast cancer: A complex story. Inflammopharmacology 2008;16:219-226
16. Hertrampf T., Schmidt S., Seibel J., Laudenbach-Leschowsky U., Degen G.H., Diel P. Effects of genistein on the mammary gland proliferation of adult ovariectomised Wistar rats. Planta Med 2006;72:304-310
17. Peterson G. Evaluation of the biochemical targets of genistein in tumor cells. J Nutr 1995;125:784S-7849
18. Sakla M.S., Shenouda N.S., Ansell P.J., MacDonald R.S., Lubahn D.B. Genistein affects HER2 protein concentration, activation, and promoter regulation in BT-474 human breast cancer cells. Endocrine 2007;32:69-78. (Pubitemid 350242549)
19. Peng J.H., Zhu J.D., Mi M.T., Li F.J., Cai L., Dong J.Z., et al. Prepubertal genistein exposure affects erbB2/Akt signal and reduces rat mammary tumorigenesis. Eur J Cancer Prev 2010;19:110-119
20. Fan S., Meng Q., Auborn K., Carter T., Rosen E.M. BRCA1 and BRCA2 as molecular targets for phytochemicals indole-3-carbinol and genistein in breast and prostate cancer cells. Br J Cancer 2006;94:407-426 (Pubitemid 43237565)
21. Vissac-Sabatier C., Coxam V., Dechelotte P., Picherit C., Horcajada M.N., Davicco M.J., et al. Phytoestrogen-rich diets modulate expression of Brca1 and Brca2 tumor suppressor genes in mammary glands of female Wistar rats. Cancer Res 2003;63:6607-6612 (Pubitemid 37322938)
22. Mueller C.R., Roskelley C.D. Regulation of BRCA1 expression and its relationship to sporadic breast cancer. Breast Cancer Res 2003;5: 45-52. (Pubitemid 36553579)
23. Marquis S.T., Rajan J.V., Wynshaw-Boris A., Xu J., Yin G.Y., Abel K.J., et al. The developmental pattern of BRCA1 expression implies a role in differentiation of the breast and other tissues. Nat Genet 1995;11: 17-26.
24. Katiyar P., Ma Y., Fan S., Pestell R.G., Furth P.A., Rosen EM. Regulation of progesterone receptor signaling by BRCA1 in mammary cancer. Nucl Recept Signal 2006;4:e006.
25. Liu S., Ginestier C., Charafe-Jauffret E., Foco H., Kleer C.G., Merajver S.D., et al. BRCA1 regulates human mammary stem/progenitor cell fate. Proc Natl Acad Sci U S A 2008;105:1680-1685 (Pubitemid 351346574)
26. King M.C., Marks J.H., Mandell J.B. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 2003;302: 643-646 (Pubitemid 37310920)
27. Antonio A.C., Pharoah P.D., Easton D.F., Evans D.G. BRCA1 and BRCA2 cancer risks. J Clin Oncol 2006;24:3312-3313
28. McBryan J., Howlin J., Napoletano S., Martin F. Amphiregulin: Role in mammary gland development and breast cancer. J Mammary Gland Biol Neoplasia 2008;13:159-169
29. Kenney N.J., Smith G.H., Rosenberg K., Cutler M.L., Dickson R.B. Induction of ductal morphogenesis and lobular hyperplasia by amphiregulin in the mouse mammary gland. Cell Growth Differ 1996;17:1769-1781 (Pubitemid 26415174)
30. Ciarloni L., Mallepell S., Brisken C. Amphiregulin is an essential mediator of estrogen receptor alpha function in mammary gland development. Proc Natl Acad Sci U S A 2007;104:5455-5460 (Pubitemid 47175701)
31. Lamber E.P., Horwitz A.A., Parvin J.D. BRCA1 represses amphiregulin gene expression. Cancer Res 2010;70:996-1005.
32. Booth B.W., Boulanger C.A., Anderson L.H., Jimenez-Rojo L., Brisken C., Smith G.H. Amphiregulin mediates self-renewal in an immortal mammary epithelial cell line with stem cell characteristics. Exp Cell Res 2010;316:422-432
33. Beleut M., Rajaram R.D., Caikovski M., Ayyanan A., Germano D., Choi Y., et al. Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland. Proc Natl Acad Sci U S A 2010;107:2989-2994
34. Zhang Y., Li Q., Wan H.Y., Helferich W.G., Wong M.S. Genistein and a soy extract differentially affect three-dimensional bone parameters and bone-specific gene expression in ovariectomized mice. J Nutr 2009;139:2230-2236
35. Li Y., Kucuk O., Hussain M., Abrams J., Cher M.L., Sarkar F.H. Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/MMP-9 signaling in prostate cancer. Cancer Res 2006;66:4816-4825
36. Boecker W., Moll R., Dervan P., Buerger H., Poremba C., Diallo R.I., et al. Usual ductal hyperplasia of the breast is a committed stem (progenitor) cell lesion distinct from atypical ductal hyperplasia and ductal carcinoma in situ. J Pathol 2002;198:458-467. (Pubitemid 35446999)
37. Hilakivi-Clarke L., Cho E., Raygada M., Kenney N. Alterations in mammary gland development following neonatal exposure to estradiol, transforming growth factor alpha, and estrogen receptor antagonist ICI 182,780. J Cell Physiol 1997;170:279-289 (Pubitemid 27117912)
38. Russo I.H., Russo J. Mammary gland neoplasia in long-term rodent studies. Environ Health Perspect 1996;104:938-967 (Pubitemid 26372400)
39. Allred D.C., Harvey J.M., Berardo M., Clark G.M. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 1998;11:155-168 (Pubitemid 28144151)
40. Tan-Wong S.M., French J.D., Proudfoot N.J., Brown M.A. Dynamic interactions between the promoter and terminator regions of the mammalian BRCA1 gene. Proc Natl Acad Sci U S A 2008;105: 5160-5165 (Pubitemid 351738527)
41. Nannuru K.C., Futakuchi M., Sadanandam A., Wilson T.J., Varney M.L., Myers K.J., et al. Enhanced expression and shedding of receptor activator of NF-kappaB ligand during tumor-bone interaction potentiates mammary tumor-induced osteolysis. Clin Exp Metastasis 2009;26:797-808.
42. Wang X.Y., Yin Y., Yuan H., Sakamaki T., Okano H., Glazer R.I. Musashi1 modulates mammary progenitor cell expansion through proliferinmediated activation of the Wnt and Notch pathways. Mol Cell Biol 2008;28:3589-99.
43. Allred CD, Allred KF, Ju YH, Goeppinger TS, Doerge DR, Helferich WG. Soy processing influences growth of estrogen-dependent breast cancer tumors. Carcinogenesis 2004;25:1649-1657
44. Poole A.J., Li Y., Kim Y., Lin S.C., Lee W.H., Lee E.Y. Prevention of Brca1- mediated mammary tumorigenesis in mice by a progesterone antagonist. Science 2006;314:1467-1470 (Pubitemid 44871955)
45. Yin Y., Russell R.G., Dettin L.E., Bai R., Wei Z., Kozikowski A.P., et al. Peroxisome proliferator-activated receptor delta and gamma agonists differentially alter tumor differentiation and progression during mammary carcinogenesis. Cancer Res 2005;65:3950-3957 (Pubitemid 40616378)
46. Pei R.J., Sato M., Yuri T., Danbara N., Nikaido Y., Tsubura A. Effect of prenatal and prepubertal genistein exposure on N-methyl-N-nitrosourea- induced mammary tumorigenesis in female Sprague-Dawley rats. In Vivo 2003;17:349-357 (Pubitemid 36958129)
47. Joshi P.A., Jackson H.W., Beristain A.G., Di Grappa M.A., Mote P.A., Clarke C.L., et al. Progesterone induces adult mammary stem cell expansion. Nature 2010;465:803-807
48. Wietrzyk J., Mazurkiewicz M., Madej J., Dzimira S., Grynkiewicz G., Radzikowski C., et al. Genistein alone or combined with cyclophosphamide may stimulate 16/C transplantable mouse mammary cancer growth. Med Sci Monit 2004;10:BR414-BR419
49. Sternlicht M.D., Sunnarborg S.W. The ADAM17-amphiregulin-EGFR axis in mammary development and cancer. J Mammary Gland Biol Neoplasia 2008;13:181-194
50. Harris R.C., Chung E., Coffey R.J. EGF receptor ligands. Exp Cell Res 2003;284:2-13. (Pubitemid 36331964)
51. Kenney N.J., Huang R.P., Johnson G.R., Wu J.X., Okamura D., Matheny W., et al. Detection and location of amphiregulin and Cripto-1 expression in the developing postnatal mouse mammary gland. Mol Reprod Dev 1995;41:277-286
52. Gierach G.L., Loud J.T., Chow C.K., Prindiville S.A., Eng-Wong J., Soballe P.W., et al. Mammographic density does not differ between unaffected BRCA1/2 mutation carriers and women at low-to-average risk of breast cancer. Breast Cancer Res Treat 2010;123:245-255
53. Mitchell G., Antoniou A.C., Warren R., Peock S., Brown J., Davies R., et al. Mammographic density and breast cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Res 2006;66:1866-1872 (Pubitemid 43259974)
54. Triplett A.A., Montagna C., Wagner K.U. A mammary-specific, longrange deletion on mouse chromosome 11 accelerates Brca1-associated mammary tumorigenesis. Neoplasia 2008;10:1325-1334
55. Xu X., Wagner K.U., Larson D., Weaver Z., Li C., Ried T., et al. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat Genet 1999;22:37-43. (Pubitemid 29214802)
56. Hoshino A., Yee C.J., Campbell M., Woltjer R.L., Townsend RL, van der MR, et al. Effects of BRCA1 transgene expression on murine mammary gland development and mutagen-induced mammary neoplasia. Int J Biol Sci 2007;3:281-291 (Pubitemid 46707828)
57. Jones L.P., Tilli M.T., Assefnia S., Torre K., Halama E.D., Parrish A., et al. Activation of estrogen signaling pathways collaborates with loss of Brca1 to promote development of ERa-negative and ERapositive mammary preneoplasia and cancer. Oncogene 2008;27: 794-802. (Pubitemid 351186312)